Cancer Research Institute honors Rafi Ahmed with William B. Coley Award

The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, has selected Rafi Ahmed, PhD, to receive the 2017 William B. Coley Award for Distinguished Research in Basic Immunology. Ahmed is director of the Emory Vaccine Center, professor of microbiology and immunology in Emory University School of Medicine, an investigator in the Emory Center for AIDS Research, and a Georgia Research Alliance Eminent Scholar. He is also a faculty member in the IMP and MMG programs.

CRI will bestow its highest honors on Ahmed for his fundamental contributions to the fields of immunology and cancer immunotherapy. The award will be presented at the Institute’s 31st Annual Awards Dinner on Tuesday, Nov. 14, 2017 at The Plaza Hotel in New York City.

Ahmed, a member of Winship Cancer Institute of Emory University, is recognized for his seminal work on immune memory as well as his definitive studies on the role of the PD-1 receptor in T cell exhaustion during chronic infection. His work significantly influenced the clinical development of anti-PD-1/PD-L1 immunotherapies, five of which have now received FDA approval in the treatment of cancer. Notably, one of these became the first cancer treatment ever to be approved for cancers with a specific genetic biomarker, regardless of their origin.

Click here to view the full story in the Emory News Center.